Google has spent the past few years in a constant state of AI escalation, rolling out new versions of its Gemini models and integrating that technology into every feature possible . To say this has been an annoyance for Google's userbase would be an understatement. Still, the AI-fueled evolution of Google products continues unabated—except for Google Photos. After waffling on how to handle changes to search in Photos, Google has relented and will add a simple toggle to bring back the classic search experience.

The rollout of the Gemini-powered Ask Photos search experience has not been smooth. According to Google Photos head Shimrit Ben-Yair, the company has heard the complaints. As a result, Google Photos will soon make it easy to go back to the traditional, non-Gemini search system.

If you weren't using Google Photos from the start, it can be hard to understand just how revolutionary the search experience was. We went from painstakingly scrolling through timelines to find photos to being able to just search for what was in them. This application of artificial intelligence predates the current obsession with generative systems, and that's why Google decided a few years ago it had to go.

Read full article

Comments

Google has spent the past few years in a constant state of AI escalation, rolling out new versions of its Gemini models and integrating that technology into every feature possible . To say this has been an annoyance for Google's userbase would be an understatement. Still, the AI-fueled evolution of Google products continues unabated—except for Google Photos. After waffling on how to handle changes to search in Photos, Google has relented and will add a simple toggle to bring back the classic search experience.

The rollout of the Gemini-powered Ask Photos search experience has not been smooth. According to Google Photos head Shimrit Ben-Yair, the company has heard the complaints. As a result, Google Photos will soon make it easy to go back to the traditional, non-Gemini search system.

If you weren't using Google Photos from the start, it can be hard to understand just how revolutionary the search experience was. We went from painstakingly scrolling through timelines to find photos to being able to just search for what was in them. This application of artificial intelligence predates the current obsession with generative systems, and that's why Google decided a few years ago it had to go.

Read full article

Comments

Google has spent the past few years in a constant state of AI escalation, rolling out new versions of its Gemini models and integrating that technology into every feature possible . To say this has been an annoyance for Google's userbase would be an understatement. Still, the AI-fueled evolution of Google products continues unabated—except for Google Photos. After waffling on how to handle changes to search in Photos, Google has relented and will add a simple toggle to bring back the classic search experience.

The rollout of the Gemini-powered Ask Photos search experience has not been smooth. According to Google Photos head Shimrit Ben-Yair, the company has heard the complaints. As a result, Google Photos will soon make it easy to go back to the traditional, non-Gemini search system.

If you weren't using Google Photos from the start, it can be hard to understand just how revolutionary the search experience was. We went from painstakingly scrolling through timelines to find photos to being able to just search for what was in them. This application of artificial intelligence predates the current obsession with generative systems, and that's why Google decided a few years ago it had to go.

Read full article

Comments

Anthropic sued the Trump administration yesterday in an attempt to reverse the government's decision to blacklist its technology. Anthropic argues that it exercised its First Amendment rights by refusing to let its Claude AI models be used for autonomous warfare and mass surveillance of Americans and that the government blacklisted it in retaliation.

"When Anthropic held fast to its judgment that Claude cannot safely or reliably be used for autonomous lethal warfare and mass surveillance of Americans, the President directed every federal agency to 'IMMEDIATELY CEASE all use of Anthropic's technology'—even though the Department of War had previously agreed to those same conditions," Anthropic said in a lawsuit in US District Court for the Northern District of California. "Hours later, the Secretary of War [Pete Hegseth] directed his Department to designate Anthropic a 'Supply-Chain Risk to National Security,' and further directed that 'effective immediately, no contractor, supplier, or partner that does business with the United States military may conduct any commercial activity with Anthropic.'"

Anthropic said the First Amendment gives it "the right to express its views—both publicly and to the government—about the limitations of its own AI services and important issues of AI safety." Anthropic further argued that the process for designating it a supply chain risk did not comply with the procedures mandated by Congress. The supply chain risk designation is supposed to be used only to protect against risks that an adversary may sabotage systems used for national security, the lawsuit said.

Read full article

Comments

Anthropic sued the Trump administration yesterday in an attempt to reverse the government's decision to blacklist its technology. Anthropic argues that it exercised its First Amendment rights by refusing to let its Claude AI models be used for autonomous warfare and mass surveillance of Americans and that the government blacklisted it in retaliation.

"When Anthropic held fast to its judgment that Claude cannot safely or reliably be used for autonomous lethal warfare and mass surveillance of Americans, the President directed every federal agency to 'IMMEDIATELY CEASE all use of Anthropic's technology'—even though the Department of War had previously agreed to those same conditions," Anthropic said in a lawsuit in US District Court for the Northern District of California. "Hours later, the Secretary of War [Pete Hegseth] directed his Department to designate Anthropic a 'Supply-Chain Risk to National Security,' and further directed that 'effective immediately, no contractor, supplier, or partner that does business with the United States military may conduct any commercial activity with Anthropic.'"

Anthropic said the First Amendment gives it "the right to express its views—both publicly and to the government—about the limitations of its own AI services and important issues of AI safety." Anthropic further argued that the process for designating it a supply chain risk did not comply with the procedures mandated by Congress. The supply chain risk designation is supposed to be used only to protect against risks that an adversary may sabotage systems used for national security, the lawsuit said.

Read full article

Comments

Anthropic sued the Trump administration yesterday in an attempt to reverse the government's decision to blacklist its technology. Anthropic argues that it exercised its First Amendment rights by refusing to let its Claude AI models be used for autonomous warfare and mass surveillance of Americans and that the government blacklisted it in retaliation.

"When Anthropic held fast to its judgment that Claude cannot safely or reliably be used for autonomous lethal warfare and mass surveillance of Americans, the President directed every federal agency to 'IMMEDIATELY CEASE all use of Anthropic's technology'—even though the Department of War had previously agreed to those same conditions," Anthropic said in a lawsuit in US District Court for the Northern District of California. "Hours later, the Secretary of War [Pete Hegseth] directed his Department to designate Anthropic a 'Supply-Chain Risk to National Security,' and further directed that 'effective immediately, no contractor, supplier, or partner that does business with the United States military may conduct any commercial activity with Anthropic.'"

Anthropic said the First Amendment gives it "the right to express its views—both publicly and to the government—about the limitations of its own AI services and important issues of AI safety." Anthropic further argued that the process for designating it a supply chain risk did not comply with the procedures mandated by Congress. The supply chain risk designation is supposed to be used only to protect against risks that an adversary may sabotage systems used for national security, the lawsuit said.

Read full article

Comments

For the second time, Vinay Prasad is set to leave the Food and Drug Administration.

In a post on social media Friday, FDA Commissioner Marty Makary announced that Prasad will exit in April, adding that he got "a tremendous amount accomplished" during his year at the agency.

Prasad's tenure was generally marked by controversy, but he is departing amid a cluster of self-destructive decisions. Those include a shocking rejection of an mRNA vaccine (which was over the objections of agency scientists and quickly reversed); a demand for an additional clinical trial on a gene therapy for Huntington's disease, which was widely seen as moving the goalpost for the therapy; his startling choice to publicly attack the maker of that gene therapy, UniQure; and alleged abuse of FDA staff, who say he created a toxic work environment .

Read full article

Comments

For the second time, Vinay Prasad is set to leave the Food and Drug Administration.

In a post on social media Friday, FDA Commissioner Marty Makary announced that Prasad will exit in April, adding that he got "a tremendous amount accomplished" during his year at the agency.

Prasad's tenure was generally marked by controversy, but he is departing amid a cluster of self-destructive decisions. Those include a shocking rejection of an mRNA vaccine (which was over the objections of agency scientists and quickly reversed); a demand for an additional clinical trial on a gene therapy for Huntington's disease, which was widely seen as moving the goalpost for the therapy; his startling choice to publicly attack the maker of that gene therapy, UniQure; and alleged abuse of FDA staff, who say he created a toxic work environment .

Read full article

Comments

For the second time, Vinay Prasad is set to leave the Food and Drug Administration.

In a post on social media Friday, FDA Commissioner Marty Makary announced that Prasad will exit in April, adding that he got "a tremendous amount accomplished" during his year at the agency.

Prasad's tenure was generally marked by controversy, but he is departing amid a cluster of self-destructive decisions. Those include a shocking rejection of an mRNA vaccine (which was over the objections of agency scientists and quickly reversed); a demand for an additional clinical trial on a gene therapy for Huntington's disease, which was widely seen as moving the goalpost for the therapy; his startling choice to publicly attack the maker of that gene therapy, UniQure; and alleged abuse of FDA staff, who say he created a toxic work environment .

Read full article

Comments